Abstract:Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease (COVID-19), induced a global pandemic with a diverse array of clinical manifestations. While the acute phase of the pandemic may be waning, the intricacies of COVID-19's impact on neurological health remain a crucial area of investigation. Early recognition of the spectrum of COVID-19 symptoms, ranging from mild fever and cough to life-threatening respiratory distress and multi-organ failure, underscored the significance of neurological complications, including anosmia, seizures, stroke, disorientation, encephalopathy, and paralysis. Notably, patients requiring intensive care unit (ICU) admission due to neurological challenges or due to them exhibiting neurological abnormalities in the ICU have shown increased mortality rates. COVID-19 can lead to a range of neurological complications such as anosmia, stroke, paralysis, cranial nerve deficits, encephalopathy, delirium, meningitis, seizures, etc., in affected patients. This review elucidates the burgeoning landscape of neurological sequelae associated with SARS-CoV-2 infection and explores the underlying neurobiological mechanisms driving these diverse manifestations. A meticulous examination of potential neuroinvasion routes by SARS-CoV-2 underscores the intricate interplay between the virus and the nervous system. Moreover, we dissect the diverse neurological manifestations emphasizing the necessity of a multifaceted approach to understanding the disease's neurological footprint. In addition to elucidating the pathophysiological underpinnings, this review surveys current therapeutic modalities and delineates prospective avenues for neuro-COVID research. By integrating epidemiological, clinical, and diagnostic parameters, we endeavor to foster a comprehensive analysis of the nexus between COVID-19 and neurological health, thereby laying the groundwork for targeted therapeutic interventions and long-term management strategies.

Extracellular Vesicles: The Invisible Heroes and Villains of COVID-19 Central Neuropathology

Emerging Roles of Extracellular Vesicles in COVID‐19, a Double‐edged Sword?

Extracellular vesicles in the pathogenesis of neurotropic viruses

The Potential Role of Extracellular Vesicles in COVID-19 Treatment: Opportunity and Challenge

Extracellular vesicles in neuroinflammation: Pathogenesis, diagnosis, and therapy

Extracellular vesicles: Critical bilateral communicators in periphery-brain crosstalk in central nervous system disorders

Recent Advances on Extracellular Vesicles in Central Nervous System Diseases

COVID-19: Neuroinvasiveness, Neurotropism and Neurovirulence

SARS-CoV-2 and the central nervous system: Emerging insights into hemorrhage-associated neurological consequences and therapeutic considerations

Extracellular vesicles, from the pathogenesis to the therapy of neurodegenerative diseases

A Review of Extracellular Vesicles in COVID‐19 Diagnosis, Treatment, and Prevention

The complexity of extracellular vesicles: Bridging the gap between cellular communication and neuropathology

Extracellular Vesicles as a Translational Approach for the Treatment of COVID-19 Disease: An Updated Overview

The neurobiology of SARS-CoV-2 infection

Understanding the neurotropic characteristics of SARS-CoV-2: from neurological manifestations of COVID-19 to potential neurotropic mechanisms

Extracellular Vesicles: Versatile Nanomediators, Potential Biomarkers and Therapeutic Agents in Atherosclerosis and COVID-19-Related Thrombosis

Immune mediating molecules and pathogenesis of COVID-19-associated neurological disease

Brain Pathology in COVID-19: Clinical Manifestations and Potential Mechanisms

Neurological Complications of COVID-19: Unraveling the Pathophysiological Underpinnings and Therapeutic Implications

COVID-19 and central nervous system interplay: A big picture beyond clinical manifestation

Exploring the role of brain-derived extracellular vesicles in viral infections: from pathological insights to biomarker potential